In this commentary, Robert Rosenson, MD, explains that PCSK9 inhibitors may be a useful alternative therapy in lowering LDL cholesterol in individuals who are unable to tolerate statins at the doses...
Consultant360 spoke with Dr James L Januzzi Jr, who recently co-authored the “2017 ACC Expert Consensus Decision Pathway for Optimization of Heart Failure Treatment: Answers to 10 Pivotal Issues About Heart...
In part 4 of our series on lipid management, Paul Jellinger, MD, explains the answer to the quiz question from part 3 of the series and talks about the role of the MESA Study in the treatment of...
During his session at the InterPro AFib Forum, Christian T. Ruff, MD, MPH, from Brigham and Women's Hospital, spoke about managing antithrombotic therapy in AFib and CAD.
Bruce Y. Lee, MD, from the Global Obesity Prevention Center at Johns Hopkins, explains what a systems approach is, how you can use them to better manage your patients' cardiometabolic health...
Bruce Y. Lee, MD, from the Global Obesity Prevention Center at Johns Hopkins, explains what a systems approach is, how you can use them to better manage your patients' cardiometabolic health...
Brendan M. Everett, MD, MPH, from Harvard Medical School answers our questions about his session at the World Congress Insulin Resistance Diabetes & Cardiovascular Disease conference.
Dr Laxmi Mehta, from Ohio State University, talks about coronary disease treatments for pregnant women, gives an example of a challenging patient case, and elaborates on the role of statins in the treatment...
In this commentary, Dr Seth Martin explains the updates to the Friedewald estimation that he hopes more labs will adopt to ensure LDL assessments are as accurate as possible.
